Institutional Ownership
Gain Therapeutics Inc
CUSIP 36269B105COMGANXQ1 2026
Institutional Holders
39
13F filers
Shares Held
7.55M
Aggregate institutional
Institutional Value
$12.83M
Q1 2026
Net New Holders
-9
7 new · 16 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions7
Increased9
Decreased10
Sold out16
Institutional Holders
39 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Marshall Wace, LLP | 1.77M | $3.43M | +107.5K | Added |
| 2 | Potomac Capital Management, Inc. | 1.01M | $1.96M | −1.4K | Reduced |
| 3 | Jones Financial Companies Lllp | 631.6K | $1.16M | −70.6K | Reduced |
| 4 | Dme Capital Management, LP | 566.1K | $1.10M | 0 | Held |
| 5 | Geode Capital Management, LLC | 447.3K | $868.5K | +49.4K | Added |
| 6 | Susquehanna International Group, LLP | 431.3K | $836.7K | −253.1K | Reduced |
| 7 | Blackrock, Inc. | 225.0K | $436.6K | +15.5K | Added |
| 8 | Ubs Group AG | 220.5K | $427.7K | +139.4K | Added |
| 9 | Jane Street Group, LLC | 216.9K | $420.8K | −25.4K | Reduced |
| 10 | Cresset Asset Management, LLC | 160.0K | $310.4K | 0 | Held |
29 more institutional holders on Premium
See every fund holding Gain Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders